Sort
48,018 grants matching “immunotherapy”
preclinical optimization of BCMA directed T cell therapy
$590,784Marta Chesi · Mayo Clinic Arizona · R01 · FY2024 · CA
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic
$590,750Sunil Krishnan · Mayo Clinic Jacksonville · R01 · FY2022 · CA
Real time scattered x-ray imaging for tumor motion tracking in radiotherapy.
$590,726Xun Jia · Johns Hopkins University · R01 · FY2024 · CA
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
$590,685Yuanpei Li · University Of California At Davis · R01 · FY2024 · DE
Designing T cells to Functionally Cure HIV-1 infection
$590,667James L Riley · University Of Pennsylvania · U19 · FY2017 · AI
A PILOT STUDY OF DUAL IMMUNOTHERAPY (PD1/CD73) IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH PANCREATIC ADENOCARCINOMA: IMMUNE MECHANISMS OF RESISTANCE
$590,625University Of California, Los Angeles · · FY2025 · Defense Health Agency
A PILOT STUDY OF DUAL IMMUNOTHERAPY (PD1/CD73) IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH PANCREATIC ADENOCARCINOMA: IMMUNE MECHANISMS OF RESISTANCE
$590,625University Of California, Los Angeles · · FY2025 · Defense Health Agency
Immune Correlates of Protection Against SIVE
$590,545Susan Valerie Westmoreland · Harvard Medical School · R01 · FY2008 · NS
Immune Correlates of Protection Against SIVE
$590,528Shawn Patrick O'Neil · Harvard Medical School · R01 · FY2007 · NS
POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION
$590,392Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$590,346Cristian T Badea · Duke University · U24 · FY2019 · CA
Induced tolerogenic dendritic cell therapy of allergic diseases
$590,342Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2015 · AI
Monoclonal antibody isolation and characterization
$590,254Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
$590,248Tyler Dallas Bold · University Of Minnesota · R01 · FY2023 · AI
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
$590,248Tyler Dallas Bold · University Of Minnesota · R01 · FY2024 · AI
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
$590,248Tyler Dallas Bold · University Of Minnesota · R01 · FY2025 · AI
Administrative Core
$590,179Jun Yan · University Of Louisville · P20 · FY2024 · GM
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
$590,079Zhihua Jiang · University Of Florida · R01 · FY2022 · HL
Mechanoregulation of cytotoxic lymphocyte function
$590,065Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2021 · AI
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$590,031Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
$590,000Robert Michael Angelo · Stanford University · UH3 · FY2019 · CA
New tools for tracking single cells in vivo
$589,925Guillem Pratx · Stanford University · R01 · FY2024 · EB
Toward translation of a plant virus-based in situ vaccination nanotechnology
$589,872Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA